Status:

COMPLETED

The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)

Lead Sponsor:

University of Massachusetts, Worcester

Conditions:

Inflammatory Bowel Diseases

Eligibility:

All Genders

15+ years

Phase:

NA

Brief Summary

The goal of this study is to prospectively test the hypothesis that specific dietary modification can improve patient symptoms by promoting beneficial changes in the composition of the microbiome that...

Detailed Description

The gut microbiome is the community of microbes that inhabit the gastrointestinal tract. Sequencing and analysis of the DNA and/or RNA of the gut microbiome (metagenomics) allow the identification of ...

Eligibility Criteria

Inclusion

  • \- 15 years of age or older
  • Willingness and capacity to significantly change diet
  • Willing and able to comply with scheduled visits, blood, and stool collection, and other study procedures and to complete the study
  • Clinical provider (GI clinician) permission for IBD patients to participate in the intervention is required for participation in the study.
  • Evidence of personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study.
  • For children age 15 and above, the assent of the child and consent of a parent or legal guardian will be required.
  • One of the following:
  • diagnosis of IBD, specifically Crohn's Disease and Ulcerative Colitis
  • healthy control

Exclusion

  • the presence of infection (such as C.diff) precipitating the colitis
  • antibiotics taken within 3 months of study entry
  • medically unstable to give consent
  • on heparin or Coumadin
  • Prisoners
  • Subjects who do not speak or understand English, to ensure that there is consistency in teaching and educational materials.
  • Subjects who self-report current pregnancy
  • Patients who do not receive clinical care at UMass Memorial Health Care

Key Trial Info

Start Date :

February 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2019

Estimated Enrollment :

38 Patients enrolled

Trial Details

Trial ID

NCT04757181

Start Date

February 1 2017

End Date

June 1 2019

Last Update

February 17 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Massachusetts Medical School

Worcester, Massachusetts, United States, 01655